S. aureus vaccine development

CARB-X global partnership headed toward developing an innovative vaccine against potentially deadly Staphylococcus aureus bacteria that could be a “game changer” in stemming antimicrobial resistance (AMR).

 

Share This

Facebook
Twitter
LinkedIn

CATEGORIES

RECENT POSTS

SUBSCRIBE HERE!

Subscribe to the IBT Bioservices Tech Talk list and receive periodic updates on industry news and IBT Bioservices products and services.

You may also like

Search
Generic filters